A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

Clinical trial NCT07540897 · RECRUITING

Trial details

NCT number: NCT07540897
Sponsor: Alkermes, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2026-08-01
Primary completion: 2027-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.